PRODUCT DETAILS
- RLD: VFEND®
- Concentration: 200 mg per vial
- Fill Volume: 20 mL extractable volume after reconstitution of lyophilized powder
- Therapeutic Class: Antifungal
PRODUCT DETAILS
| Concentration | NDC Number | Saleable Unit | Wholesaler Numbers |
|---|---|---|---|
| 200 mg per vial | 70436-029-80 | 20 mL vial Lyophilized Powder Box of 1 vial | Cardinal Health: 5570809 |
| McKesson: 3984028 | |||
| Amerisource: 10229760 |
A single dose vial as a sterile lyophilized powder equivalent to 200 mg voriconazole and 3,200 mg sulfobutyl ether beta-cyclodextrin sodium (SBECD).
Voriconazole for injection unreconstituted vials should be stored at 15°C to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. The reconstituted solution should be used immediately.
We have been made aware of recent scams that offer false employment opportunities or request financial commitments purportedly on behalf of Slate Run Pharmaceuticals. Unsuspecting job seekers have reported receiving unsolicited contacts such as e-mails and phone calls which may request personal information or offers of employment. Please note that these communications are fraudulent and are not affiliated with Slate Run Pharmaceuticals. Slate Run Pharmaceuticals never requires a financial deposit for employment consideration nor do we offer unsolicited employment packages.
You can reach out to Slate Run Pharmaceuticals at http://www.slaterunpharma.com/get-in-touch/. If you receive a suspicious proposal, please contact your local law enforcement agency for guidance.